Dare Bioscience (DARE) Equity Ratio (2016 - 2025)
Dare Bioscience's Equity Ratio history spans 11 years, with the latest figure at 0.09 for Q4 2025.
- For Q4 2025, Equity Ratio rose 132.18% year-over-year to 0.09; the TTM value through Dec 2025 reached 0.09, up 132.18%, while the annual FY2025 figure was 0.09, 132.18% up from the prior year.
- Equity Ratio reached 0.09 in Q4 2025 per DARE's latest filing, down from 0.09 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.69 in Q4 2021 to a low of 0.98 in Q2 2025.
- Average Equity Ratio over 5 years is 0.08, with a median of 0.1 recorded in 2024.
- Peak YoY movement for Equity Ratio: surged 1338.57% in 2021, then plummeted 966.86% in 2025.
- A 5-year view of Equity Ratio shows it stood at 0.69 in 2021, then crashed by 63.49% to 0.25 in 2022, then crashed by 193.54% to 0.24 in 2023, then fell by 14.69% to 0.27 in 2024, then soared by 132.18% to 0.09 in 2025.
- Per Business Quant, the three most recent readings for DARE's Equity Ratio are 0.09 (Q4 2025), 0.09 (Q3 2025), and 0.98 (Q2 2025).